
PRLD EPS Estimates
Prelude Therapeutics Incorporated
$3.32
-$0.09(-2.64%)
37
Overall
60
Value
30
Tech
23
Quality
Market Cap
$264.95M
Volume
422.33K
52W Range
$1.30 - $6.83
Target Price
$9.00
PRLD EPS estimates: the consensus estimate for Prelude Therapeutics Incorporated's current fiscal year is -$0.57 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PRLD EPS Estimates
- EPS estimate, current quarter
- $-0.14
- EPS estimate, next quarter
- $-0.16
- EPS estimate, current year
- $-0.57
- EPS estimate, next year
- $-0.73
- EPS growth, 3-year
- +23.77%
| Fiscal year | EPS |
|---|---|
| 2024 | $-1.68 |
| 2023 | $-2.02 |
| 2022 | $-2.44 |
| 2021 | $-2.43 |
| 2020 | $-4.56 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $3.32 | -2.6% | 422.33K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW